| Literature DB >> 32372993 |
Jenny Zaehringer1,2, Christine Jennen-Steinmetz3, Christian Schmahl1,4, Gabriele Ende2, Christian Paret1,5.
Abstract
Assessing psychophysiological responses of emotion regulation is a cost-efficient way to quantify emotion regulation and to complement subjective report that may be biased. Previous studies have revealed inconsistent results complicating a sound interpretation of these findings. In the present study, we summarized the existing literature through a systematic search of articles. Meta-analyses were used to evaluate effect sizes of instructed downregulation strategies on common autonomic (electrodermal, respiratory, cardiovascular, and pupillometric) and electromyographic (corrugator activity, emotion-modulated startle) measures. Moderator analyses were conducted, with moderators including study design, emotion induction, control instruction and trial duration. We identified k = 78 studies each contributing multiple sub-samples and performed 23 meta-analyses for combinations of emotion regulation strategy and psychophysiological measure. Overall, results showed that effects of reappraisal and suppression on autonomic measures were highly inconsistent across studies with rather small mean effect sizes. Electromyography (startle and corrugator activity) showed medium effect sizes that were consistent across studies. Our findings highlight the diversity as well as the low level of standardization and comparability of research in this area. Significant moderation of effects by study design, trial duration, and control condition emphasizes the need for better standardization of methods. In addition, the small mean effect sizes resulting from our analyses on autonomic measures should be interpreted with caution. Findings corroborate the importance of multi-channel approaches.Entities:
Keywords: autonomic nervous system; electromyography; emotion regulation; meta-analysis; psychophysiology; reappraisal; suppression
Year: 2020 PMID: 32372993 PMCID: PMC7177019 DOI: 10.3389/fpsyg.2020.00470
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Emotion downregulation processes and their strategies considered in this meta-analysis.
| Attentional deployment | Distraction | Active distraction | Participants are instructed to think about something positive or neutral that is unrelated to the target emotion/stimulus |
| Cognitive Change | Reappraisal | Reinterpret the emotional stimulus | Participants are instructed to reinterpret the emotional stimulus to decrease the target emotion |
| Reappraise via perspective taking, i.e., distancing | participants are instructed to alter the impact of a stimulus by adopting a more objective perspective | ||
| Reappraise Mixed | A mixture of reappraisal instructions | ||
| Response modulation | Suppression | Suppress the expression of emotion | Participants are instructed to hide the way they are feeling, e.g., not to smile |
| Suppress the experience of an emotion | Participants are instructed to suppress their emotional experience | ||
| Suppress thoughts of the emotion eliciting event | Participant are instructed to suppress thoughts about the emotion-eliciting event | ||
| Suppression mixed | A mixture of suppression instructions | ||
| Downregulation unspecified | Own choice | Own choice | Participants are free to choose a strategy that works best for them. They are not allowed to create a different emotion or think of something unrelated to the stimulus |
| No instruction (C1) | No instructions are given | ||
| Instructions not to regulate (C2) | Participants are told that they should not use a regulation strategy | ||
| Instructions to maintain (C3) | Participants are instructed to maintain the target emotion | ||
| Instructions to experience naturally (C4) | Participants are instructed to respond naturally without regulating it | ||
| Control mixed (C5) | A mixture of control instructions | ||
Common psychophysiological measures of emotion regulation studies.
| Cardiovascular | Cardiac output | CO | l/min | Blood volume pumped by the heart per minute. |
| Lowest blood pressure of circulating blood on the walls of blood vessels in between two heartbeats, measured in millimeters of mercury. | ||||
| Time interval between the R-wave of the electrocardiogram to the pulse wave arrival at the ear. | ||||
| Amplitude of the pulse waveform measured in the finger. Indicator of dilation and constriction of the blood vessels. | ||||
| Time interval between the R-wave of the electrocardiogram to the pulse wave arrival at the finger. | ||||
| Number of beats per unit of time/time between heart beats (inverse of heart rate). | ||||
| Variation in heart rate. Refers specifically to the high-frequency HRV [also called respiratory sinus arrhythmia (RSA)]. | ||||
| Low frequency HRV | LF | Units vary by method | Variation in heart rate. Refers specifically to the low-frequency HRV. | |
| Ratio of low- and high-frequency HRV | LF/HF | Units vary by method | Variation in heart rate. Refers specifically to the ratio between low- and high-frequency HRV. | |
| Mean blood pressure of circulating blood on the walls of blood vessels in between two heartbeats, measured in millimeters of mercury. | ||||
| Pre-ejection period | PEP | ms | Period between the beginning of electrical stimulation of the heart to the opening of the aortic valve. Indicator of the cardiac contractile force (i.e., how hard the heart is beating). | |
| Stroke volume | SV | mL | Volume of blood pumped from the left ventricle per beat. | |
| Maximum blood pressure of circulating blood on the walls of blood vessels in between two heartbeats, measured in millimeters of mercury. | ||||
| Total peripheral resistance | TPR | Unity vary by method | Overall resistance that must be overcome to push blood through the whole circulatory system (i.e., all major arterial trees). | |
| Electrodermal | Peak amplitude, magnitude or local maximum of the skin conductance response. Includes non-specific skin conductance responses during longer periods of time if reported as amplitude. | |||
| Mean change of skin conductance over a specific period of time. Operationalized as simple average, change from baseline, area under the curve or integrated signal. | ||||
| Number of skin conductance responses | nSCR | n | Number of skin responses per unit of time (e.g. per minute). | |
| Respiratory | Inspiration/expiration time | IT/ET | sec | Average inhalation/exhalation time per respiratory cycle. |
| Difference in volts between the point of maximum inspiration and the point of maximum expiration. | ||||
| Respiration rate | RR | c/min | Number of breaths per minute. | |
| Tidal volume | TV | mL | Air volume that moves into or out of the lungs while breathing quietly. | |
| Pupillometric | Average diameter of pupil in millimeter during a specific period of time. | |||
| Electromyographic | Amplitude of the startle eyeblink response (orbicularis oculi) in response to affective stimuli. | |||
| Muscular activity of the corrugator supercilii responsible for furrowing of the brow. | ||||
| Zygomaticus major activity | zEMG | MicroVolt | Muscular activity of the zygomaticus major responsible for smiling. | |
| Other | Temperature of the finger, in Fahrenheidt (F) or Celcius (C°). |
The measures in bold were included in our meta-analysis; for the other measures the number of studies was insufficient (k < 5 studies per cell). Because heart rate (HR) and interbeat interval (IBI) are inversely related, we switched the direction of the effect sizes when IBI was extracted (instead of HR). Descriptions derived and adapted from Berntson et al. (.
Characteristics and effect sizes for studies included in the meta–analyses.
| Ajaya et al. ( | Reappraisal | HRV | Anger | B | 120 | Anger task | C1 | 66 | 60.61 | 20.62 | 40 | −0.10 |
| Aldao and Mennin ( | Reappraisal | HRV | Disgust, fear, sadness | B | 62 | F | C1 | 58 | 56.90 | 29.57 | 38 | 0.75 |
| Azbel-Jackson et al. ( | Suppression | HR | Negative | B | 7 | I | C2 | 60 | 70.00 | 21.50 | 60 | −0.22 |
| Azbel-Jackson et al. ( | Suppression | SCL | Negative | B | 7 | I | C2 | 60 | 70.00 | 21.50 | 60 | −0.04 |
| Azbel-Jackson et al. ( | Suppression | HR | Negative | B | 7 | I | C2 | 80 | 85.00 | 22.20 | 40 | 0.40 |
| Azbel-Jackson et al. ( | Suppression | SCL | Negative | B | 7 | I | C2 | 80 | 85.00 | 22.20 | 40 | 0.73 |
| Bebko et al. ( | Reappraisal | PD | Negative | W | 10 | I | C4 | 84 | 47.62 | 19.67 | 40 | −0.09 |
| Ben-Naim et al. ( | Reappraisal | FPA | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 86 | −1.52 |
| Ben-Naim et al. ( | Reappraisal | FPTT | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 86 | −0.18 |
| Ben-Naim et al. ( | Reappraisal | HR | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 86 | 0.33 |
| Ben-Naim et al. ( | Reappraisal | SCL | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 86 | 0.16 |
| Ben-Naim et al. ( | Reappraisal | SCR | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 86 | −0.39 |
| Ben-Naim et al. ( | Suppression | EPPT | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 85 | 0.09 |
| Ben-Naim et al. ( | Suppression | FPA | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 85 | −0.66 |
| Ben-Naim et al. ( | Suppression | FPTT | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 85 | −0.32 |
| Ben-Naim et al. ( | Suppression | HR | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 85 | 0.35 |
| Ben-Naim et al. ( | Suppression | SCL | Negative | B | 900 | Dyadic | C1 | 254 | 50.00 | 24.00 | 85 | 0.04 |
| Braams et al. ( | Suppression | HR | Fear | B | 16.5 | ToS | C1 | 123 | 46.34 | 21.70 | 62 | −0.04 |
| Bulut et al. ( | Reappraisal | HRV | Negative | B | 300 | I | C4 | 28 | 67.86 | 23.67 | 28 | 0.47 |
| Butler et al. ( | Suppression | MAP | Negative | B | Dyadic | C1 | 72 | 100.00 | 20.30 | 60 | −0.09 | |
| Butler et al. ( | Reappraisal | HR | Negative | B | 590.8 | Dyadic | C1 | 190 | 100.00 | 20.00 | 62 | −0.24 |
| Butler et al. ( | Reappraisal | HRV | Negative | B | 590.8 | Dyadic | C1 | 190 | 100.00 | 20.00 | 62 | 0.51 |
| Butler et al. ( | Reappraisal | RA | Negative | B | 590.8 | Dyadic | C1 | 190 | 100.00 | 20.00 | 62 | 0.12 |
| Butler et al. ( | Suppression | HR | Negative | B | 570.6 | Dyadic | C1 | 190 | 100.00 | 20.00 | 69 | 0.10 |
| Butler et al. ( | Suppression | HRV | Negative | B | 570.6 | Dyadic | C1 | 190 | 100.00 | 20.00 | 69 | 0.39 |
| Butler et al. ( | Suppression | RA | Negative | B | 570.6 | Dyadic | C1 | 190 | 100.00 | 20.00 | 69 | −0.76 |
| Butler et al. ( | Reappraisal | SCL | Negative | B | 590.8 | Dyadic | C1 | 190 | 14.74 | 20.10 | 61 | −0.28 |
| Butler et al. ( | Suppression | SCL | Negative | B | 570.6 | Dyadic | C1 | 190 | 14.74 | 20.10 | 68 | −0.26 |
| Chu et al. ( | Reappraisal | HR | Anger | B | 10 | Anger task | C1 | 68 | 54.41 | 40.00 | 68 | −0.14 |
| Colby et al. ( | Suppression | SCL | Fear | W | 6 | ToS | C4 | 10 | 0.00 | 10 | −0.11 | |
| Conzelmann et al. ( | Own choice | Startle | Negative | W | 8 | I | C3 | 31 | 48.39 | 22.00 | 31 | −0.60 |
| Dan-Glauser and Gross ( | Suppression | FT | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.16 |
| Dan-Glauser and Gross ( | Suppression | HR | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.57 |
| Dan-Glauser and Gross ( | Suppression | MAP | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.07 |
| Dan-Glauser and Gross ( | Suppression | RA | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.82 |
| Dan-Glauser and Gross ( | Suppression | FPA | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | 0.42 |
| Dan-Glauser and Gross ( | Suppression | FPTT | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.13 |
| Dan-Glauser and Gross ( | Suppression | FT | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.16 |
| Dan-Glauser and Gross ( | Suppression | HR | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.71 |
| Dan-Glauser and Gross ( | Suppression | MAP | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.50 |
| Dan-Glauser and Gross ( | Suppression | RA | Negative | W | 8 | I | C4 | 37 | 100.00 | 20.20 | 37 | −0.45 |
| Demaree et al. ( | Suppression | HR | Disgust | B | 120 | F | C4 | 69 | 52.17 | 19.32 | 35 | 0.09 |
| Demaree et al. ( | Suppression | HRV | Disgust | B | 120 | F | C4 | 69 | 52.17 | 19.32 | 35 | 0.21 |
| Demaree et al. ( | Suppression | RA | Disgust | B | 120 | F | C4 | 69 | 52.17 | 19.32 | 35 | 0.43 |
| Demaree et al. ( | Suppression | SCL | Disgust | B | 120 | F | C4 | 69 | 52.17 | 19.32 | 35 | 0.12 |
| Denson et al. ( | Reappraisal | HR | Fear | B | 600 | Stress | C1 | 90 | 52.22 | 20.54 | 90 | −0.09 |
| Denson et al. ( | Reappraisal | HR | Fear | B | 300 | Stress | C1 | 90 | 52.22 | 20.54 | 86 | −0.07 |
| Denson et al. ( | Reappraisal | HRV | Anger | B | 180 | F | C1 | 131 | 100.00 | 20.23 | 86 | 0.37 |
| Denson et al. ( | Suppression | HR | Anger | B | 180 | F | C1 | 131 | 100.00 | 20.23 | 89 | 0.25 |
| Denson et al. ( | Suppression | HRV | Anger | B | 180 | F | C1 | 131 | 100.00 | 20.23 | 89 | 0.17 |
| Deveney and Pizzagalli ( | Reappraisal | cEMG | Negative | W | 5 | I | C3 | 32 | 78.13 | 23.97 | 26 | −0.09 |
| Di Simplicio et al. ( | Reappraisal | HR | Negative | W | 4 | I | C4 | 30 | 53.33 | 28.59 | 20 | 0.00 |
| Di Simplicio et al. ( | Reappraisal | HRV | Negative | W | 4 | I | C4 | 30 | 53.33 | 28.59 | 20 | 0.05 |
| Di Simplicio et al. ( | Reappraisal | HR | Negative | W | 4 | I | C4 | 30 | 53.33 | 28.59 | 10 | 0.09 |
| Di Simplicio et al. ( | Reappraisal | HRV | Negative | W | 4 | I | C4 | 30 | 53.33 | 28.59 | 10 | −0.15 |
| Dillon and LaBar ( | Own choice | Startle | Negative | W | 12 | I | C3 | 48 | 77.08 | 22.00 | 12 | −0.09 |
| Dillon and LaBar ( | Own choice | Startle | Negative | W | 12 | I | C3 | 48 | 77.08 | 22.00 | 12 | −0.75 |
| Efinger et al. ( | Reappraisal | HR | Negative | W | 8 | I | C4 | 77 | 100.00 | 20.70 | 77 | −0.27 |
| Efinger et al. ( | Reappraisal | RA | Negative | W | 8 | I | C4 | 77 | 100.00 | 20.70 | 77 | 0.06 |
| Efinger et al. ( | Reappraisal | SCL | Negative | W | 8 | I | C4 | 77 | 100.00 | 20.70 | 77 | −0.19 |
| Efinger et al. ( | Distraction | SCL | Negative | W | 8 | I | C4 | 77 | 100.00 | 20.70 | 77 | −0.27 |
| Fitzpatrick and Kuo ( | Distraction | SCL | Negative | W | 10 | I | 30 | 66.67 | 30.07 | 30 | 0.00 | |
| Fuentes-Sánchez et al. ( | Reappraisal | SCR | Negative | W | 8 | I | C4 | 122 | 59.02 | 25.10 | 106 | −0.01 |
| Goldin et al. ( | Reappraisal | HR | Negative | W | 12 | Self-belief | C4 | 35 | 57.14 | 32.20 | 35 | −0.03 |
| Goldin et al. ( | Reappraisal | SCL | Negative | W | 12 | Self-belief | C4 | 35 | 57.14 | 32.20 | 35 | −0.01 |
| Golkar et al. ( | Own choice | Startle | Negative | W | 5 | I | C2 | 61 | 54.10 | 30.90 | 61 | −0.47 |
| Gomez et al. ( | Reappraisal | SCR | Disgust | B | 10 | I | C1 | 81 | 64.20 | 28.15 | 40 | −0.11 |
| Gross and Levenson ( | Suppression | EPPT | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | 0.07 |
| Gross and Levenson ( | Suppression | FPA | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | −0.38 |
| Gross and Levenson ( | Suppression | FPTT | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | −0.24 |
| Gross and Levenson ( | Suppression | FT | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | −0.30 |
| Gross and Levenson ( | Suppression | HR | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | −0.53 |
| Gross and Levenson ( | Suppression | RA | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | −0.18 |
| Gross and Levenson ( | Suppression | SCL | Disgust | B | 64 | F | C1 | 43 | 0.00 | 19.30 | 43 | 0.24 |
| Gross and Levenson ( | Suppression | EPPT | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | −0.55 |
| Gross and Levenson ( | Suppression | FPA | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | −0.81 |
| Gross and Levenson ( | Suppression | FPTT | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | 0.21 |
| Gross and Levenson ( | Suppression | FT | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | −0.96 |
| Gross and Levenson ( | Suppression | HR | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | −0.21 |
| Gross and Levenson ( | Suppression | RA | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | 0.11 |
| Gross and Levenson ( | Suppression | SCL | Disgust | B | 64 | F | C1 | 42 | 100.00 | 19.20 | 42 | 0.46 |
| Gross and Levenson ( | Suppression | SCL | Sadness | B | 210 | F | C1 | 180 | 100.00 | 180 | 0.29 | |
| Gross ( | Reappraisal | FPA | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | 0.12 |
| Gross ( | Reappraisal | FT | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | −0.33 |
| Gross ( | Reappraisal | HR | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | −0.09 |
| Gross ( | Reappraisal | SCL | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | −0.19 |
| Gross ( | Suppression | FPA | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | −0.60 |
| Gross ( | Suppression | FT | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | −1.04 |
| Gross ( | Suppression | HR | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | 0.02 |
| Gross ( | Suppression | SCL | Disgust | B | 64 | F | C1 | 120 | 50.00 | 21.00 | 80 | 0.41 |
| Hagemann et al. ( | Suppression | EPPT | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | −0.38 |
| Hagemann et al. ( | Suppression | FPA | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | −0.25 |
| Hagemann et al. ( | Suppression | FPTT | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | −0.39 |
| Hagemann et al. ( | Suppression | FT | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | −0.55 |
| Hagemann et al. ( | Suppression | HR | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | 0.73 |
| Hagemann et al. ( | Suppression | HRV | Negative | B | 20 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | −0.34 |
| Hagemann et al. ( | Suppression | SCL | Negative | B | 5 | ToS, I | C1 | 252 | 51.98 | 20.50 | 168 | 0.49 |
| Hallam et al. ( | Reappraisal | SCL | Negative | W | 10 | I | C4 | 40 | 50.00 | 20.00 | 26 | 0.00 |
| Hallam et al. ( | Suppression | SCL | Negative | W | 10 | I | C4 | 40 | 50.00 | 20.00 | 26 | −0.01 |
| Jackson et al. ( | Own choice | Startle | Negative | W | 14 | I | C3 | 48 | 68.75 | 20.50 | 44 | −1.04 |
| Kim and Hamann ( | Reappraisal | cEMG | Negative | W | 24 | I | C4 | 36 | 50.00 | 20.19 | 33 | −0.30 |
| Kim and Hamann ( | Reappraisal | SCR | Negative | W | 24 | I | C4 | 36 | 50.00 | 20.19 | 32 | 0.11 |
| Kinner et al. ( | Reappraisal | PD | Negative | W | 5 | I | C4 | 30 | 100.00 | 24.40 | 28 | 0.26 |
| Kinner et al. ( | Reappraisal | SCR | Negative | W | 5 | I | C4 | 30 | 100.00 | 24.40 | 25 | 0.00 |
| Kunzmann et al. ( | Suppression | HR | Disgust | W | 117 | F | C1 | 95 | 49.47 | 46.00 | 47 | −0.26 |
| Kunzmann et al. ( | Suppression | SCL | Disgust | W | 117 | F | C1 | 95 | 49.47 | 46.00 | 47 | 0.15 |
| Leiberg et al. ( | Reappraisal | SCR | Negative | W | 6 | I | C4 | 24 | 100.00 | 24.10 | 24 | 0.17 |
| Lohani and Isaacowitz ( | Reappraisal | cEMG | Sadness | W | 300 | F | C1 | 48 | 79.17 | 71.42 | 42 | −0.17 |
| Lohani and Isaacowitz ( | Reappraisal | SCL | Sadness | W | 300 | F | C1 | 42 | 73.81 | 18.50 | 40 | 0.56 |
| Lohani and Isaacowitz ( | Suppression | SCL | Sadness | W | 300 | F | C1 | 42 | 73.81 | 18.50 | 40 | 0.52 |
| Lohani and Isaacowitz ( | Reappraisal | cEMG | Sadness | W | 300 | F | C1 | 42 | 73.81 | 18.50 | 40 | −0.30 |
| Lohani and Isaacowitz ( | Reappraisal | SCL | Sadness | W | 300 | F | C1 | 48 | 79.17 | 71.42 | 44 | 0.09 |
| Lohani and Isaacowitz ( | Suppression | SCL | Sadness | W | 300 | F | C1 | 48 | 79.17 | 71.42 | 44 | 0.13 |
| Lohani and Isaacowitz ( | Distraction | SCL | Sadness | W | 300 | F | C1 | 42 | 73.81 | 18.50 | 40 | 0.48 |
| Lohani and Isaacowitz ( | Distraction | SCL | Sadness | W | 300 | F | C1 | 48 | 79.17 | 71.42 | 44 | 0.24 |
| Low et al. ( | Reappraisal | HR | Negative | B | 600 | Stress | C3 | 81 | 58.02 | 20.60 | 56 | 0.29 |
| Martins et al. ( | Reappraisal | PD | Negative | W | 7 | I | C4 | 48 | 68.75 | 69.10 | 48 | 0.06 |
| Martins et al. ( | Reappraisal | PD | Negative | W | 7 | I | C4 | 48 | 60.42 | 21.06 | 48 | 0.06 |
| Morawetz et al. ( | Reappraisal | SCR | Negative | W | 8 | I, F | C4 | 59 | 33.90 | 32.47 | 47 | 0.08 |
| Morawetz et al. ( | Reappraisal | SCR | Negative | W | 8 | I | C4 | 23 | 52.17 | 25.70 | 16 | −0.19 |
| Morawetz et al. ( | Reappraisal | SCR | Negative | W | 8 | F | C4 | 23 | 65.22 | 22.95 | 22 | −0.03 |
| Ohira et al. ( | Suppression | HR | Negative | W | 60 | I | C4 | 10 | 100.00 | 24.22 | 9 | 0.04 |
| Opitz et al. ( | Reappraisal | cEMG | Sadness | W | 8 | I | C4 | 30 | 53.33 | 61.90 | 29 | −0.43 |
| Opitz et al. ( | Reappraisal | HR | Sadness | W | 8 | I | C4 | 30 | 63.33 | 19.45 | 28 | −0.02 |
| Opitz et al. ( | Reappraisal | SCL | Sadness | W | 8 | I | C4 | 30 | 63.33 | 19.45 | 27 | −0.02 |
| Opitz et al. ( | Reappraisal | cEMG | Sadness | W | 8 | I | C4 | 30 | 63.33 | 19.45 | 28 | −1.07 |
| Opitz et al. ( | Reappraisal | HR | Sadness | W | 8 | I | C4 | 30 | 53.33 | 61.90 | 29 | −0.14 |
| Opitz et al. ( | Reappraisal | SCL | Sadness | W | 8 | I | C4 | 30 | 53.33 | 61.90 | 29 | −0.27 |
| Ortner ( | Reappraisal | SCR | Negative | B | 8 | I | C1 | 120 | 75.83 | 76 | 0.01 | |
| Plieger et al. ( | Reappraisal | SCL | Negative | W | 4.5 | I | C1 | 91 | 82.42 | 24.53 | 91 | −0.28 |
| Richards and Gross ( | Suppression | DBP | Negative | B | 84 | I | C1 | 85 | 100.00 | 18.80 | 74 | 0.36 |
| Richards and Gross ( | Suppression | FT | Negative | B | 84 | I | C1 | 85 | 100.00 | 18.80 | 74 | −0.37 |
| Richards and Gross ( | Suppression | HR | Negative | B | 84 | I | C1 | 85 | 100.00 | 18.80 | 74 | −0.11 |
| Richards and Gross ( | Suppression | SBP | Negative | B | 84 | I | C1 | 85 | 100.00 | 18.80 | 74 | 0.27 |
| Richards and Gross ( | Suppression | SCL | Negative | B | 84 | I | C1 | 85 | 100.00 | 18.80 | 74 | −0.14 |
| Roberts et al. ( | Suppression | DBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.91 |
| Roberts et al. ( | Suppression | HR | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | −0.23 |
| Roberts et al. ( | Suppression | SBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.60 |
| Roberts et al. ( | Suppression | SCL | Negative | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.00 |
| Roberts et al. ( | Suppression | DBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.84 |
| Roberts et al. ( | Suppression | HR | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.08 |
| Roberts et al. ( | Suppression | SBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.66 |
| Roberts et al. ( | Suppression | SCL | Negative | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.35 |
| Roberts et al. ( | Suppression | DBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | −0.31 |
| Roberts et al. ( | Suppression | HR | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | −0.61 |
| Roberts et al. ( | Suppression | SBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.01 |
| Roberts et al. ( | Suppression | SCL | Negative | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.62 |
| Roberts et al. ( | Suppression | DBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.12 |
| Roberts et al. ( | Suppression | HR | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.26 |
| Roberts et al. ( | Suppression | SBP | Disgust | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.11 |
| Roberts et al. ( | Suppression | SCL | Negative | B | 62 | F | C1 | 40 | 60.00 | 20.80 | 40 | 0.30 |
| Robinson and Demaree ( | Suppression | HR | Sadness | W | 120 | F | C4 | 102 | 50.98 | 19.75 | 102 | −0.23 |
| Robinson and Demaree ( | Suppression | HRV | Sadness | W | 120 | F | C4 | 102 | 50.98 | 19.75 | 102 | 0.41 |
| Robinson and Demaree ( | Suppression | SCL | Sadness | W | 120 | F | C4 | 102 | 50.98 | 19.75 | 102 | 0.26 |
| Rohrmann et al. ( | Reappraisal | HR | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | 0.22 |
| Rohrmann et al. ( | Reappraisal | HR | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | −0.34 |
| Rohrmann et al. ( | Suppression | HR | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | 0.47 |
| Rohrmann et al. ( | Suppression | HR | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | −0.66 |
| Rohrmann et al. ( | Reappraisal | SCL | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | 0.35 |
| Rohrmann et al. ( | Reappraisal | SCL | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | −0.57 |
| Rohrmann et al. ( | Suppression | SCL | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | 0.85 |
| Rohrmann et al. ( | Suppression | SCL | Disgust | B | 60 | F | C1 | 120 | 0.00 | 25.47 | 36 | −0.23 |
| Roth et al. ( | Suppression | SCL | Fear | B | 197 | F | C1 | 116 | 60.34 | 24.90 | 65 | −0.04 |
| Roth et al. ( | Distraction | SCL | Fear | B | 197 | F | C1 | 116 | 60.34 | 24.90 | 67 | −0.77 |
| Sheppes et al. ( | Reappraisal | FT | Sadness | B | 190 | F | C5 | 45 | 100.00 | 22.90 | 29 | 0.22 |
| Sheppes et al. ( | Reappraisal | SCL | Sadness | B | 190 | F | C5 | 45 | 100.00 | 22.90 | 29 | 1.13 |
| Sheppes et al. ( | Distraction | SCL | Sadness | B | 190 | F | C5 | 45 | 100.00 | 22.90 | 29 | 0.23 |
| Shermohammed et al. ( | Reappraisal | HR | Negative | W | 8 | I | C1 | 25 | 48.00 | 20.89 | 19 | 0.65 |
| Shermohammed et al. ( | Reappraisal | SCR | Negative | W | 8 | I | C1 | 25 | 48.00 | 20.89 | 17 | 0.12 |
| Shiota and Levenson ( | Suppression | DBP | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 73 | −0.66 |
| Shiota and Levenson ( | Suppression | EPPT | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 74 | 0.33 |
| Shiota and Levenson ( | Suppression | FPA | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 75 | 0.49 |
| Shiota and Levenson ( | Suppression | FPTT | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 75 | −0.12 |
| Shiota and Levenson ( | Suppression | FT | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 76 | −0.24 |
| Shiota and Levenson ( | Suppression | HR | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 75 | −0.40 |
| Shiota and Levenson ( | Suppression | MAP | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 73 | −0.66 |
| Shiota and Levenson ( | Suppression | RA | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 72 | −0.29 |
| Shiota and Levenson ( | Suppression | SBP | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 73 | −0.69 |
| Shiota and Levenson ( | Suppression | SCL | Disgust | W | 180 | F | C4 | 76 | 50.00 | 25.50 | 73 | −0.42 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 23 | 0.37 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 23 | 0.47 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 23 | 0.36 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 23 | −0.29 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 22 | −0.34 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 25.50 | 23 | −0.27 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 25 | 0.14 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 25 | 0.02 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 26 | 0.12 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 25 | −0.11 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 24 | −0.10 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 25.30 | 24 | 0.10 |
| Shiota and Levenson ( | Suppression | DBP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 64 | −0.27 |
| Shiota and Levenson ( | Suppression | EPPT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 71 | −0.06 |
| Shiota and Levenson ( | Suppression | FPA | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 71 | 0.27 |
| Shiota and Levenson ( | Suppression | FPTT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 72 | 0.11 |
| Shiota and Levenson ( | Suppression | FT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 72 | −0.03 |
| Shiota and Levenson ( | Suppression | HR | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 72 | −0.30 |
| Shiota and Levenson ( | Suppression | MAP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 64 | −0.28 |
| Shiota and Levenson ( | Suppression | RA | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 66 | −0.07 |
| Shiota and Levenson ( | Suppression | SBP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 64 | −0.32 |
| Shiota and Levenson ( | Suppression | SCL | Disgust | W | 180 | F | C4 | 72 | 50.00 | 44.70 | 69 | −0.39 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 23 | 0.23 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 24 | −0.28 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 24 | 0.00 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 24 | −0.31 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 23 | −0.18 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 22 | 50.00 | 44.70 | 22 | −0.10 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 26 | 0.17 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 26 | 0.21 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 26 | 0.23 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 26 | −0.06 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 24 | −0.10 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 26 | 50.00 | 43.20 | 25 | −0.09 |
| Shiota and Levenson ( | Suppression | DBP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 69 | −0.30 |
| Shiota and Levenson ( | Suppression | EPPT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 68 | −0.01 |
| Shiota and Levenson ( | Suppression | FPA | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 65 | 0.23 |
| Shiota and Levenson ( | Suppression | FPTT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 65 | 0.16 |
| Shiota and Levenson ( | Suppression | FT | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 72 | 0.11 |
| Shiota and Levenson ( | Suppression | HR | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 69 | −0.12 |
| Shiota and Levenson ( | Suppression | MAP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 69 | −0.30 |
| Shiota and Levenson ( | Suppression | RA | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 66 | −0.26 |
| Shiota and Levenson ( | Suppression | SBP | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 69 | −0.27 |
| Shiota and Levenson ( | Suppression | SCL | Disgust | W | 180 | F | C4 | 72 | 50.00 | 64.80 | 69 | −0.46 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 23 | −0.08 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 23 | 0.03 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 24 | 0.10 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 23 | −0.19 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 20 | −0.19 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.80 | 23 | −0.11 |
| Shiota and Levenson ( | Reappraisal | FPA | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 22 | 0.40 |
| Shiota and Levenson ( | Reappraisal | FPTT | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 22 | −0.12 |
| Shiota and Levenson ( | Reappraisal | FT | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 23 | 0.58 |
| Shiota and Levenson ( | Reappraisal | HR | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 22 | −0.10 |
| Shiota and Levenson ( | Reappraisal | RA | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 22 | −0.26 |
| Shiota and Levenson ( | Reappraisal | SCL | Disgust, sadness | W | 180 | F | C4 | 24 | 50.00 | 64.50 | 22 | −0.64 |
| Soto et al. ( | Suppression | HR | Disgust | W | 58 | F | C1 | 59 | 54.24 | 19.51 | 48 | −0.19 |
| Soto et al. ( | Suppression | SCL | Disgust | W | 58 | F | C1 | 59 | 54.24 | 19.51 | 47 | −0.15 |
| Stiller et al. ( | Reappraisal | HR | Negative | B | 165 | F | C2 | 61 | 73.77 | 24.30 | 41 | 0.15 |
| Stiller et al. ( | Reappraisal | SCL | Negative | B | 165 | F | C2 | 61 | 73.77 | 24.30 | 41 | 0.49 |
| Stiller et al. ( | Suppression | HR | Negative | B | 165 | F | C2 | 61 | 73.77 | 24.30 | 40 | 0.58 |
| Stiller et al. ( | Suppression | SCL | Negative | B | 165 | F | C2 | 61 | 73.77 | 24.30 | 40 | 0.35 |
| Strauss et al. ( | Reappraisal | PD | Negative | W | 5 | I | C4 | 25 | 64.00 | 19.80 | 25 | 0.14 |
| Svaldi et al. ( | Reappraisal | FPTT | Sadness | W | 125 | F | C1 | 25 | 100.00 | 38.30 | 21 | −0.11 |
| Svaldi et al. ( | reappraisal | HR | Sadness | W | 125 | F | C1 | 25 | 100.00 | 38.30 | 25 | −0.32 |
| Svaldi et al. ( | reappraisal | HRV | Sadness | W | 125 | F | C1 | 25 | 100.00 | 38.30 | 21 | −0.67 |
| Svaldi et al. ( | reappraisal | SCL | Sadness | W | 125 | F | C1 | 25 | 100.00 | 38.30 | 23 | 0.10 |
| Svaldi et al. ( | Suppression | FPTT | Sadness | W | 211 | F | C1 | 25 | 100.00 | 38.30 | 21 | −0.68 |
| Svaldi et al. ( | Suppression | HR | Sadness | W | 211 | F | C1 | 25 | 100.00 | 38.30 | 25 | −0.16 |
| Svaldi et al. ( | Suppression | HRV | Sadness | W | 211 | F | C1 | 25 | 100.00 | 38.30 | 21 | −0.18 |
| Svaldi et al. ( | Suppression | SCL | Sadness | W | 211 | F | C1 | 25 | 100.00 | 38.30 | 23 | 0.50 |
| Urry et al. ( | Reappraisal | PD | Negative | W | 5 | I | C3 | 17 | 52.94 | 62.90 | 14 | 0.43 |
| Urry et al. ( | Reappraisal | PD | Negative | W | 8 | I | C3 | 26 | 57.69 | 64.80 | 26 | 0.46 |
| Urry et al. ( | Reappraisal | SCL | Negative | W | 8 | I | C3 | 26 | 57.69 | 64.80 | 26 | −0.42 |
| Urry ( | Reappraisal | cEMG | Negative | W | 8 | I | C2 | 41 | 63.41 | 20.00 | 40 | 0.03 |
| Urry ( | Reappraisal | HR | Negative | W | 8 | I | C2 | 41 | 63.41 | 20.00 | 40 | −0.14 |
| Urry ( | Reappraisal | SCR | Negative | W | 8 | I | C2 | 41 | 63.41 | 20.00 | 39 | 0.18 |
| Urry ( | Reappraisal | cEMG | Negative | W | 4 | I | C4 | 54 | 48.15 | 18.80 | 54 | −0.32 |
| Urry ( | Reappraisal | HR | Negative | W | 4 | I | C4 | 54 | 48.15 | 18.80 | 53 | 0.03 |
| Urry ( | Reappraisal | SCL | Negative | W | 4 | I | C4 | 54 | 48.15 | 18.80 | 52 | 0.03 |
| Uy et al. ( | Suppression | HRV | Disgust | W | 133 | F | C1 | 7 | 57.14 | 29.80 | 7 | 0.45 |
| van Reekum et al. ( | Reappraisal | PD | Negative | W | 8 | I | C4 | 29 | 62.07 | 63.00 | 21 | 0.53 |
| Williams et al. ( | Reappraisal | HR | Fear | B | 180 | Stress | C1 | 39 | 64.10 | 20.60 | 26 | −0.15 |
| Williams et al. ( | Reappraisal | HR | Fear | B | 180 | Stress | C1 | 47 | 65.96 | 21.30 | 30 | 0.05 |
| Wolgast et al. ( | Reappraisal | cEMG | Disgust, fear, Sadness | B | 153 | F | C1 | 94 | 51.06 | 27.40 | 62 | −0.79 |
| Wolgast et al. ( | Reappraisal | SCL | Disgust, fear, Sadness | B | 153 | F | C1 | 94 | 51.06 | 27.40 | 62 | −0.87 |
| Wu et al. ( | Reappraisal | SCL | Sadness | B | 180 | F | C1 | 42 | 100.00 | 22.31 | 42 | −0.18 |
| Yuan et al. ( | Suppression | SCL | Anger | B | 1800 | Anger task | C1 | 64 | 0.00 | 29.52 | 43 | −0.72 |
cEMG, corrugator electromyography; DBP, diastolic blood pressure; EPTT, ear pulse transit time; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; HRV, heart rate variability; MAP, mean arterial pressure; PD, pupil dilation; RA, respiration amplitude; SBP, systolic blood pressure; SCL, skin conductance level; SCR, skin conductance response; B, between–subject design study; W, within–subject design study; F, film; I, images; C1, no instruction given (“view”); C2, instruction not to regulate; C3, instruction to maintain target emotion; C4, instruction to respond naturally; C5, a combination of C1–C4; Ntotal, number of participants in the study; Nanalyzed, number of participants in the subsample.
Figure 1PRISMA flowchart of the literature search process.
Figure 2Number of available effect sizes for each measure as a function of emotion regulation strategy (distraction, reappraisal, suppression, own choice). Note that the statistic refers to the k = 78 studies initially identified in our qualitative analysis. cEMG, corrugator activity; CO, cardiac output; DBP, diastolic blood pressure; EPA, ear pulse amplitude; EPTT, ear pulse transit time; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; HRV, heart rate variability; LF, low frequency HRV; LF/HF, ratio between low and high frequency HRV; MAP, mean arterial pressure; nSCR, number of skin conductance responses; PD, pupil dilation; PEP, pre-ejection period; RA, respiration amplitude; RR, respiration rate; SBP, systolic blood pressure; SCL, skin conductance level; SCR, skin conductance response; SV, stroke volume; TPR, total peripheral resistance; zEMG, zygomatic activity.
Mean computed effect sizes for each emotion regulation strategy and psychophysiological measure.
| Electrodermal | ||||||||||
| SCL | 6 | −0.004 | 0.175 | −0.454 | 0.447 | 95.53 | 0.984 | – | ||
| Cardiovascular | ||||||||||
| FPA | 8 | −0.015 | 0.215 | −0.524 | 0.495 | 88.90 | 0.948 | – | ||
| FPTT | 8 | −0.021 | 0.074 | −0.195 | 0.153 | 24.73 | 0.785 | – | ||
| FT | 8 | 0.159 | 0.091 | −0.056 | 0.373 | 21.99 | 0.124 | – | ||
| HR | 28 | −0.092 | 0.039 | −0.171 | −0.012 | 21.91 | 0.026 | REG < CTL | ||
| HRV | 8 | 0.106 | 0.164 | −0.282 | 0.494 | 87.62 | 0.537 | – | ||
| Electrodermal | ||||||||||
| SCL | 26 | −0.065 | 0.069 | −0.206 | 0.077 | 71.11 | 0.355 | – | ||
| SCR | 12 | −0.041 | 0.031 | −0.028 | 0.109 | 33.01 | 0.218 | – | ||
| Pupillometric | ||||||||||
| PD | 8 | 0.136 | 0.071 | −0.033 | 0.305 | 69.82 | 0.098 | – | ||
| Respiratory | ||||||||||
| RA | 8 | −0.097 | 0.051 | −0.218 | 0.024 | 00.00 | 0.101 | – | ||
| Electromyographic | ||||||||||
| cEMG | 9 | −0.321 | 0.098 | −0.546 | −0.096 | 42.84 | 0.011 | REG < CTL | ||
| Cardiovascular | ||||||||||
| DBP | 8 | 0.039 | 0.199 | −0.431 | 0.510 | 83.99 | 0.849 | – | ||
| EPPT | 7 | −0.048 | 0.107 | −0.309 | 0.213 | 54.77 | 0.670 | – | ||
| FPA | 9 | −0.108 | 0.165 | −0.488 | 0.272 | 84.160 | 0.530 | – | ||
| FPTT | 9 | −0.174 | 0.100 | −0.404 | 0.057 | 70.10 | 0.121 | – | ||
| FT | 10 | −0.327 | 0.115 | −0.586 | −0.067 | 70.03 | 0.019 | REG < CTL | ||
| HR | 29 | −0.093 | 0.067 | −0.231 | 0.045 | 78.28 | 0.177 | – | ||
| HRV | 7 | 0.126 | 0.122 | −0.174 | 0.425 | 78.76 | 0.344 | – | ||
| MAP | 6 | −0.338 | 0.084 | −0.554 | −0.123 | 16.45 | 0.010 | REG < CTL | ||
| RA | 9 | −0.285 | 0.118 | −0.558 | −0.012 | 61.21 | 0.042 | REG < CTL | ||
| SBP | 8 | −0.018 | 0.164 | −0.407 | 0.371 | 78.32 | 0.917 | – | ||
| Electrodermal | ||||||||||
| SCL | 31 | 0.106 | 0.064 | −0.025 | 0.236 | 77.57 | 0.108 | – | ||
| Electromyographic | ||||||||||
| Startle | 5 | −0.621 | 0.145 | −1.021 | −0.219 | 47.35 | 0.013 | REG < CTL |
k, number of studies; SE, standard error; CI, confidence interval; cEMG, corrugator electromyography; DBP, diastolic blood pressure; EPTT, ear pulse transit time; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; HRV, heart rate variability; MAP, mean arterial pressure; PD, pupil dilation; RA, respiration amplitude; SBP, systolic blood pressure; SCL, skin conductance level; SCR, skin conductance response. I.
p ≤ 0.05,
p ≤ 0.01.
Figure 3Mean effect sizes and confidence intervals for each conducted meta-analysis (upper panel) sorted by number of samples k of the meta-analysis, respectively (lower panel). Suppr, suppression; reappr, reappraisal; distr, distraction; HR, heart rate; SCL, skin conductance level; SCR, skin conductance response; FT, finger temperature; cEMG, corrugator activity; FPA, finger pulse amplitude; FPTT, finger pulse transit time; RA, respiration amplitude; HRV, heart rate variability; PD, pupil dilation; DBP, diastolic blood pressure; SBP, systolic blood pressure; EPTT, ear pulse transit time; MAP, mean arterial pressure.
Moderator analyses on study design (within-subject design vs. between-subject design).
| Reappraisal | SCL | 26 | 17 | 9 | 1,082 | −0.001 | 0.161 | 0.997 |
| Reappraisal | HR | 28 | 16 | 12 | 1,176 | −0.131 | 0.085 | 0.134 |
| Suppression | SCL | 31 | 11 | 20 | 1,805 | −0.176 | 0.126 | 0.174 |
| Suppression | FT | 10 | 5 | 5 | 701 | 0.543 | 0.138 | 0.004 |
| Suppression | FPTT | 9 | 5 | 4 | 608 | 0.080 | 0.219 | 0.725 |
| Suppression | FPA | 9 | 4 | 5 | 666 | 0.775 | 0.115 | 0.000 |
| Suppression | RA | 9 | 5 | 4 | 467 | −0.188 | 0.263 | 0.497 |
| Suppression | HR | 29 | 10 | 19 | 1,640 | −0.379 | 0.113 | 0.002 |
k, number of studies; SE, standard error; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; RA, respiration amplitude; SCL, skin conductance level; β regression coefficient (within vs. between).
p ≤ 0.01.
Moderator analyses on nature of control instruction (instruction to respond naturally vs. no instruction).
| Reappraisal | SCL | 23 | 12 | 11 | 986 | −0.063 | 0.127 | 0.625 |
| SCR | 11 | 7 | 4 | 491 | 0.087 | 0.113 | 0.460 | |
| HR | 25 | 13 | 12 | 1,039 | −0.033 | 0.083 | 0.696 | |
| Suppression | SCL | 28 | 7 | 21 | 1,665 | −0.347 | 0.130 | 0.012 |
| FT | 10 | 5 | 5 | 701 | 0.543 | 0.138 | 0.004 | |
| FPTT | 9 | 4 | 5 | 608 | 0.422 | 0.156 | 0.030 | |
| FPA | 9 | 4 | 5 | 666 | 0.775 | 0.115 | 0.000 | |
| HR | 26 | 8 | 18 | 1,500 | −0.293 | 0.130 | 0.034 |
k, number of studies; SE, standard error; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; SCL, skin conductance level; SCR, skin conductance response; C4, instruction to respond naturally; C1, no instruction; β regression coefficient (respond naturally vs. no instruction).
p ≤ 0.05,
p ≤ 0.01.
Moderator analyses on emotion induction (films vs. pictures).
| Reappraisal | SCL | 23 | 16 | 7 | 900 | 0.126 | 0.167 | 0.458 |
| Reappraisal | HR | 20 | 12 | 8 | 723 | −0.150 | 0.086 | 0.101 |
| Suppression | SCL | 26 | 22 | 4 | 1,431 | 0.049 | 0.187 | 0.795 |
| Suppression | HR | 25 | 19 | 6 | 1,256 | 0.145 | 0.144 | 0.324 |
k, number of studies; SE, standard error; HR, heart rate; SCL, skin conductance level; β, regression coefficient (films vs. pictures).
Moderator analyses on trial duration.
| Distraction | SCL | 6 | 287 | 0.084 | 0.081 | 0.354 |
| Reappraisal | HR | 28 | 1176 | 0.015 | 0.012 | 0.209 |
| HRV | 8 | 305 | 0.071 | 0.053 | 0.232 | |
| PD | 8 | 250 | −2.492 | 1.996 | 0.258 | |
| SCL | 26 | 1,082 | 0.021 | 0.021 | 0.324 | |
| SCR | 12 | 530 | −0.028 | 0.013 | 0.053 | |
| cEMG | 9 | 354 | 0.000 | 0.051 | 0.997 | |
| Suppression | DBP | 8 | 440 | −0.408 | 0.141 | 0.028 |
| EPPT | 7 | 551 | 0.022 | 0.024 | 0.403 | |
| FPA | 9 | 666 | −0.030 | 0.039 | 0.464 | |
| FPTT | 9 | 608 | −0.011 | 0.026 | 0.677 | |
| FT | 10 | 701 | 0.130 | 0.086 | 0.172 | |
| HR | 29 | 1640 | 0.028 | 0.022 | 0.214 | |
| HRV | 7 | 491 | 0.044 | 0.047 | 0.392 | |
| RA | 9 | 467 | −0.032 | 0.048 | 0.526 | |
| SBP | 8 | 440 | −0.387 | 0.094 | 0.006 | |
| SCL | 31 | 1,805 | −0.026 | 0.012 | 0.039 |
k, number of studies; SE, standard error; cEMG, corrugator electromyography; DBP, diastolic blood pressure; EPTT, ear pulse transit time; FPA, finger pulse amplitude; FPTT, finger pulse transit time; FT, finger temperature; HR, heart rate; HRV, heart rate variability; MAP, mean arterial pressure; PD, pupil dilation; RA, respiration amplitude; SBP, systolic blood pressure; SCL, skin conductance level; SCR, skin conductance response; β regression coefficient (refers to 1 min change in trial duration).
p ≤ 0.05,
p ≤ 0.01.